가입 후 초대 링크를 공유하면 동영상 재생 및 초대 보상을 받을 수 있습니다.

Herbert Loong, MBBS, FASCO
@herbloong
Academic medical oncologist @ Hong Kong w/ interests in sarcoma medical oncology, thoracic oncology & phase 1 trials | Disclosures:
가입 October 2016
2.9K 팔로잉 중    4.8K 팬
#PingChi# from @MSKCancerCenter presented on the #final# results of FIH #NB003# trial, a potent and selective KIT inhibitor in GISTs. Broad spectrum of activity seen in different mutations. Phase 3 trial compared with #regorafenib# planned. @ctosociety @Liferaftgroup @myESMO #ESMO26# #ESMOAmbassadors#
더 보기